This paper is only available as a PDF. To read, Please Download here.
Abstract
About half of all patients on home oxygen therapy receive non-continuous oxygen therapy (less than 15 h daily) (NCOT). The goal of NCOT is to improve well-being during daily activities and to improve sleep quality. The aim of this study was to evaluate the effect of NCOT on pulmonary symptoms and sleep quality, and to determine whether patients with a subjective beneficial effect differed from those without effect in terms of patients' characteristics, utilization of oxygen, hospitalization and survival. Furthermore, the relationship between the reported beneficial effect of NCOT on dyspnoea and physical activity during domestic activities was examined. During the period November 1994 to July 1995, 254 Danish patients were prescribed oxygen less than 12 h daily or ‘on demand’. Of these patients, 142 (55·9%) answered a questionnaire on hours spent with oxygen and symptomatic effect of oxygen treatment. While on oxygen, 76·3% of the patients reported improved dyspnoea score (0–10) more than 0·5 points, 78·3% had improved quality of life, 59·5% improved sleep, 48·5% increased physical activity, 49·3% felt less tired and 40·0% reported improved thinking. Fifty-seven (43·2%) patients reported both improved dyspnoea and physical activity, whereas seven (5·3%) patients reported that oxygen had no effect on dyspnoea but a beneficial effect on physical activity. Only 11 (7·7%) patients reported no subjective improvement on oxygen. The subjective effect of NCOT was not significantly associated to hours spent with oxygen, the underlying disease, gender, hospitalization or survival. During daily activity and regardless of daily number of hours spent with oxygen, NCOT improved well-being in nearly all patients. The most pronounced improvement was reported on dyspnoea, sleep and quality of life. Very few patients sensed improved physical activity without relief in breathlessness.
Keywords
References
REFERENCES
- Supplemental oxygen therapy in COPD: is it really useful?.Thorax. 2000; 55: 537-538
- Magnitude of usage and cost of home oxygen therapy in the United States.Chest. 1995; 107: 301-302
- Lancet. 1981; i: 681-686
- Ann Intern Med. 1980; 93: 391-398
- Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia.Thorax. 1997; 52: 674-679
- A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients.Eur Respir J. 1999; 14: 1002-1008
- Am J Respir Crit Care Med. 1995; 152: 88-93
- Ambulatory oxygen in chronic heart failure.Lancet. 1992; 340: 1192-1193
- Breathlessness and portable oxygen in chronic obstructive airways disease.Thorax. 1983; 38: 302-306
- Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia.Thorax. 2000; 55: 539-543
- Ambulatory oxygen therapy in stable kyphoscoliosis.Eur Respir J. 1995; 8: 819-823
- A pragmatic assessment of the placement of oxygen when given for exercise induced dyspnoea.Thorax. 2000; 55: 544-546
- The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease.Am Rev Respir Dis. 1988; 137: 1285-1288
- Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking.Thorax. 1996; 51: 831-834
- Oxygen relieves breathlessness in ‘pink puffers’.Lancet. 1981; i: 907-909
- Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxaemia.Am J Respir Crit Care Med. 1995; 152: 1616-1619
- Domiciliary oxygen cylinders: indications, prescription and usage.Respir Med. 1994; 88: 777-785
- Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers.J R Coll Physicians Lond. 1999; 33: 445-447
- Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand.Med J Austr. 1998; 168: 21-25
- Measurement of health status. Ascertaining the minimal clinically important difference.Control Clin Trials. 1989; 10: 407-415
- Characteristics and complaints of patients prescribed long-term oxygen therapy in The Netherlands.Respir Med. 1998; 92: 70-75
- Portable liquid oxygen and exercise ability in severe respiratory disability.Thorax. 1992; 47: 781-789
- Does cold air affect exercise capacity and dyspnoea in stable chronic obstructive pulmonary disease?.Chest. 1993; 103: 693-696
- Does oxygen help dyspnoea in patients with cancer?.Am J Respir Crit Care Med. 1996; 153: 1515-1518
- Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease.Am Rev Respir Dis. 1991; 143: 913-915
- Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure.Lancet. 1992; 339: 850-853
- Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema.BMJ. 1981; 283: 878-880
- Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease.Arch Intern Med. 1984; 144: 1613-1619
- Life quality of patients with chronic obstructive pulmonary disease.Arch Intern Med. 1982; 142: 473-478
- The effect of oxygenation on sleep quality in chronic bronchitis and emphysema.Am Rev Respir Dis. 1982; 126: 206-210
- The effect of low flow oxygen on sleep disordered breathing and oxygen desaturation.Chest. 1980; 78: 682-685
- Supplemental oxygen and quality of sleep in patients with chronic obstructive lung disease.Thorax. 1989; 44: 184-188
- Acute effects of oxygen treatment upon information processing in hypoxemic COPD patients.Chest. 1985; 88: 239-243
- Neuropsychologic effects of continuous oxygen therapy in aged.Chest. 1977; 72: 737-743
- Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease.Arch Intern Med. 1983; 143: 1941-1947
Article info
Publication history
Accepted:
August 6,
2001
Received:
March 12,
2001
Identification
Copyright
© 2001 Harcourt Publishers Ltd. Published by Elsevier Inc.
User license
Elsevier user license | How you can reuse 
Elsevier's open access license policy
Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
